Health Trials

Heparin vs Placebo for Cardiac Catheterization

ConditionCardiac Disease
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18+
SponsorLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

About this trial

Patients undergoing cardiac catheterization will be randomized to 3 groups: no anticoagulant, low dose anticoagulant and high dose anticoagulant.

Eligibility criteria

Qualifiers

diagnostic cardiac catheterization; Small size sheath; patency of the ulno-palmar circulation

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Heparin
  • Placebos

Treatment groups

1,623 Participants
are divided into 3 treatment groups

Sponsors and collaborators

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Lead sponsor

Source ClinicalTrials.gov